Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
CN NHSA: Negotiated Drugs Slash Patient Burden by RMB880B+ During Agreement Period
Recommend 18 Positive 32 Negative 6 |
||||
|
||||
|
China's National Healthcare Security Administration (NHSA) announced a new version of the medical insurance drug list at a press conference this morning. An official from the NHSA said that since the list was established, the speed of including new drugs in the list has been accelerating, allowing insured citizens to promptly benefit from pharmaceutical innovations. As of the end of October 2024, negotiated drugs during the agreement period benefited a total of 830 million people, reducing the burden on patients by over RMB880 billion. AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
